News & Blog
News & Blog
CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia, a Rare Neurodegenerative Disease
Meet the Community – Fabian B
Meet the Community – Marguerite Black
Meet the Community – Katie Snead
Meet the Community 2: A Closer Look – Don Royer
Meet the Community – Silvia
Meet the Community 2: A Closer Look – Jakob Mitterhauser
Biogen Completes Acquisition of Reata Pharmaceuticals
Meet the Community 2: A Closer Look – Tiffany Rose Gambill
Meet the Community – Sam Bridgman
